Citation Impact
Citing Papers
Tet-Mediated Formation of 5-Carboxylcytosine and Its Excision by TDG in Mammalian DNA
2011 StandoutScience
Goal-directed coagulation management of major trauma patients using thromboelastometry (ROTEM®)-guided administration of fibrinogen concentrate and prothrombin complex concentrate
2010
Comparison of 2 hemostatic agents for the prevention of postextraction hemorrhage in patients on anticoagulants
2001
Recommendations on the use of recombinant activated factor VII as an adjunctive treatment for massive bleeding – a European perspective
2006
Pharmacokinetics of recombinant activated factor VII in trauma patients with severe bleeding
2006
Prevention of postoperative bleeding in anticoagulated patients undergoing oral surgery: use of platelet-rich plasma gel
2003
Anemia and Blood Transfusion in Critically Ill Patients
2002 Standout
Dental extractions in patients on warfarin: is alteration of anticoagulant regime necessary?
1998
Intracranial hemorrhage in newborn and young infants with hemophilia
1988
Duration of Red-Cell Storage and Complications after Cardiac Surgery
2008 Standout
Molecular Genetic Approaches to the Analysis and Diagnosis of Human Inherited Disease: An Overview
1992
Use of rotation thromboelastometry (ROTEM ® ) to achieve successful treatment of polytrauma with fibrinogen concentrate and prothrombin complex concentrate
2009
Effects of storage time of red blood cell transfusions on the prognosis of coronary artery bypass graft patients
2006
The Clinical Sequelae of Intravascular Hemolysis and Extracellular Plasma Hemoglobin
2005 Standout
Revalidation and update of the TASH‐Score: a scoring system to predict the probability for massive transfusion as a surrogate for life‐threatening haemorrhage after severe injury
2010
A Clinical Trial of Vena Caval Filters in the Prevention of Pulmonary Embolism in Patients with Proximal Deep-Vein Thrombosis
1998 Standout
Safety of continuing warfarin therapy during cataract surgery: A systematic review and meta-analysis
2009
Implications of preoperative administration of aspirin in patients undergoing coronary artery bypass grafting
1990
Anemia‐induced increase in the bleeding time:implications for treatment of nonsurgical blood loss
2001
mRNA-based therapeutics — developing a new class of drugs
2014 StandoutNobel
Green Chemistry: Principles and Practice
2009 Standout
Safety of dental extraction among consecutive patients on oral anticoagulant treatment managed using a specific dental management protocol
2003
Thromboelastography (TEG®) compared to conventional coagulation tests in surgical patients – a laboratory evaluation
2013
Perioperative Management of Antithrombotic Therapy
2012 Standout
The Emerging Role of Recombinant-Activated Factor VII in Neurocritical Care
2004
Instability and decay of the primary structure of DNA
1993 StandoutNatureNobel
Hemostatic effect of n-butyl-2-cyanoacrylate (histoacryl) glue in warfarin-treated patients undergoing oral surgery
2003
Impact of blood products on platelet function in patients with traumatic injuries: a translational study
2017
Emergency Hospitalizations for Adverse Drug Events in Older Americans
2011 Standout
Targeted Thromboelastographic (TEG) Blood Component and Pharmacologic Hemostatic Therapy in Traumatic and Acquired Coagulopathy
2016
Subcutaneous Low-Molecular-Weight Heparin Compared with Continuous Intravenous Heparin in the Treatment of Proximal-Vein Thrombosis
1992 Standout
Malignancies, Prothrombotic Mutations, and the Risk of Venous Thrombosis
2005 Standout
Management of bleeding following major trauma: a European guideline
2007
KEY ISSUES IN ADVANCED BLEEDING CARE IN TRAUMA
2006
Prophylactic fibrinogen infusion reduces bleeding after coronary artery bypass surgery
2009
Transfusion Medicine — Blood Transfusion
1999 Standout
Platelet Quantification and Growth Factor Analysis from Platelet-Rich Plasma: Implications for Wound Healing
2004 Standout
Heat Shock Protein A12B Protects Vascular Endothelial Cells Against Sepsis-Induced Acute Lung Injury in Mice
2017 Standout
Nitric Oxide and Peroxynitrite in Health and Disease
2007 Standout
On the need for improved transfusion indicators in cardiac surgery
1995
Frequency, risk stratification and therapeutic management of acute post‐traumatic coagulopathy
2009
The NOX Family of ROS-Generating NADPH Oxidases: Physiology and Pathophysiology
2007 Standout
Time course of haemostatic effects of fibrinogen concentrate administration in aortic surgery
2013
Cytosine Methylation and DNA Repair
2006
Recombinant Activated Factor VII for Acute Intracerebral Hemorrhage
2005 Standout
Elastic sealants for surgical applications
2015
Purification of Salmon Clotting Factors and Their Use as Tissue Sealants
2000
Dabigatran versus Warfarin in the Treatment of Acute Venous Thromboembolism
2009 Standout
Adverse Cerebral Outcomes after Coronary Bypass Surgery
1996 Standout
Antibodies against Erythropoietin and Other Protein‐Based Therapeutics: An Overview
2005
Recombinant Factor VIIa as Adjunctive Therapy for Bleeding Control in Severely Injured Trauma Patients: Two Parallel Randomized, Placebo-Controlled, Double-Blind Clinical Trials
2005
Nonaccidental Head Injury in Infants — The “Shaken-Baby Syndrome”
1998 Standout
The Clinical Course of Pulmonary Embolism
1992 Standout
11 The molecular genetics of familial venous thrombosis
1994
HIF-1α Is Essential for Myeloid Cell-Mediated Inflammation
2003 Standout
The decrease of fibrinogen is an early predictor of the severity of postpartum hemorrhage
2007
Plasma fibrinogen level, bleeding, and transfusion after on‐pump coronary artery bypass grafting surgery: a prospective observational study
2008
Antithrombotic Therapy for Venous Thromboembolic Disease
1989
Nonlinear elasticity in biological gels
2005 StandoutNature
Early coagulopathy in trauma patients: An on-scene and hospital admission study
2010
Early Coagulopathy Predicts Mortality in Trauma
2003 Standout
Fibrin Sealant Improves Hemostasis in Peripheral Vascular Surgery: A Randomized Prospective Trial
2003
Tranexamic Acid, Fibrinogen Concentrate, and Prothrombin Complex Concentrate
2013
Low-Molecular-Weight Heparin versus a Coumarin for the Prevention of Recurrent Venous Thromboembolism in Patients with Cancer
2003 Standout
???Low-Dose??? Recombinant Activated Factor VII Results in Less Blood and Blood Product Use in Traumatic Hemorrhage
2005
Randomized, Prospective Trial Comparing Bridging Therapy Using Low-Molecular-Weight Heparin With Maintenance of Oral Anticoagulation During Extraction of Teeth
2009
Dry double-sided tape for adhesion of wet tissues and devices
2019 StandoutNature
The Perioperative Management of Antithrombotic Therapy
2008
Rotational thromboelastometry significantly optimizes transfusion practices for damage control resuscitation in combat casualties
2017
The European guideline on management of major bleeding and coagulopathy following trauma: fourth edition
2016 Standout
Recombinant factor VIIA is associated with an improved 24-hour survival without an improvement in inpatient survival in massively transfused civilian trauma patients
2011
Hemostatic Management of Tooth Extractions in Patients on Oral Antithrombotic Therapy
2008
Relative concentrations of haemostatic factors and cytokines in solvent/detergent-treated and fresh-frozen plasma
2011
Haemophilia A diagnosis by analysis of a hypervariable dinucleotide repeat within the factor VIII gene
1991
Rivaroxaban versus Enoxaparin for Thromboprophylaxis after Hip Arthroplasty
2008 Standout
Impact of Hemorrhage on Trauma Outcome: An Overview of Epidemiology, Clinical Presentations, and Therapeutic Considerations
2006 Standout
Trauma, Transfusions, and Use of Recombinant Factor VIIa: A Multicenter Case Registry Report of 380 Patients from the Western Trauma Association
2010
2014 Consensus conference on viscoelastic test–based transfusion guidelines for early trauma resuscitation
2015
What do dysfunctional serpins tell us about molecular mobility and disease?
1995
Factor VIIa for Correction of Traumatic Coagulopathy
2004
World distribution of factor V Leiden
1995 Standout
Rapid genetic analysis of families with polycystic kidney disease 1 by means of a microsatellite marker
1991 StandoutNobel
Disseminated Intravascular Coagulation
1999 Standout
Massive transfusion and nonsurgical hemostatic agents
2008
Reduced mortality by meeting guideline criteria before using recombinant activated factor VII in severe trauma patients with massive bleeding
2016
Pathophysiology of Bleeding in Surgery
2006
The Pharmacology and Management of the Vitamin K Antagonists
2004 Standout
Antithrombotic Therapy for Venous Thromboembolic Disease
2001 Standout
Coagulation defects in trauma patients: etiology, recognition, and therapy
2004
The impact of fresh frozen plasma vs coagulation factor concentrates on morbidity and mortality in trauma-associated haemorrhage and massive transfusion
2011
Control of Bone Bleeding at the Sternum and Iliac Crest Donor Sites Using a Collagen-Based Composite Combined With Autologous Plasma: Results of a Randomized Controlled Trial
2001
Early coagulopathy in multiple injury: An analysis from the German Trauma Registry on 8724 patients
2007
Hemostatic Effect of Vivostat Patient-Derived Fibrin Sealant on Split-Thickness Skin Graft Donor Sites
2003
Coagulopathy and blood component transfusion in trauma
2005
Use of Low-Molecular-Weight Heparin During Dental Extractions in a Medicaid Population
2007
Damage Control Management of Experimental Grade 5 Renal Injuries: Further Evaluation of FloSeal Gelatin Matrix
2006
Preconditions of Hemostasis in Trauma: A Review. The Influence of Acidosis, Hypocalcemia, Anemia, and Hypothermia on Functional Hemostasis in Trauma
2008
A prospectus on tissue adhesives
2001
Effect of coagulation factor concentrate administration on ROTEM® parameters in major trauma
2015
Moyamoya Disease and Moyamoya Syndrome
2009 Standout
Transfusion in trauma: thromboelastometry-guided coagulation factor concentrate-based therapy versus standard fresh frozen plasma-based therapy
2011
von Willebrand disease (VWD): evidence‐based diagnosis and management guidelines, the National Heart, Lung, and Blood Institute (NHLBI) Expert Panel report (USA) 1
2008
Epstein–Barr Virus Infection
2000 Standout
Efficacy of fibrin sealant in patients on various levels of oral anticoagulant undergoing oral surgery
1998
Reduction of Fresh Frozen Plasma Requirements by Perioperative Point-of-Care Coagulation Management with Early Calculated Goal-Directed Therapy
2012
High-dose fibrinogen concentrate for haemostatic therapy of a major trauma patient with recent clopidogrel and aspirin intake
2010
Standardized Bleeding Definitions for Cardiovascular Clinical Trials
2011 Standout
Oxidants, antioxidants, and the degenerative diseases of aging.
1993 Standout
Biochemistry of Nitric Oxide and Its Redox-Activated Forms
1992 StandoutScience
Management of bleeding and coagulopathy following major trauma: an updated European guideline
2013
How I use fibrinogen replacement therapy in acquired bleeding
2014
2011 Update to The Society of Thoracic Surgeons and the Society of Cardiovascular Anesthesiologists Blood Conservation Clinical Practice Guidelines
2011 Standout
Oral surgery procedures in patients on anticoagulants. Preliminary report.
2005
Management of bleeding following major trauma: an updated European guideline
2010
Serpin Structure, Mechanism, and Function
2002 Standout
Therapeutic approaches in trauma-induced coagulopathy.
2005
A retrospective case control study of recombinant factor VIIa in patients with intracranial haemorrhage caused by trauma
2011
Inherited Thrombophilia: Part 1
1996
DNA Deaminating Ability and Genotoxicity of Nitric Oxide and its Progenitors
1991 Science
Carbohydrates of human immunodeficiency virus. Structures of oligosaccharides linked to the envelope glycoprotein 120.
1988
Can warfarin be continued during dental extraction? Results of a randomized controlled trial
2002
Dose-dependent antithrombotic effect of warfarin in rabbits
1983
Comparison of topical fibrin spray and tranexamic acid on blood loss after total knee replacement
2007
Warfarin
1984
ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease
2006 Standout
Glycobiology: Toward Understanding the Function of Sugars
1996 Standout
Regional manifestations and control of the immune system
2002
The use of FEIBA ® in the correction of coagulation abnormalities induced by dabigatran
2012
Implementation of an off-label recombinant factor VIIa protocol for patients with critical bleeding at an academic medical center
2014
Genetic Dissection of Complex Traits
1994 StandoutScience
The Effects of Protocolized Use of Recombinant Factor VIIa Within a Massive Transfusion Protocol in a Civilian Level I Trauma Center
2011
Epstein-Barr virus in benign lymph node biopsies from individuals infected with the human immunodeficiency virus is associated with concurrent or subsequent development of non-Hodgkin's lymphoma
1991
Tranexamic acid mouthwash — A prospective randomized study of a 2-day regimen vs 5-day regimen to prevent postoperative bleeding in anticoagulated patients requiring dental extractions
2003
Decrease in protein C antigen and formation of an abnormal protein soon after starting oral anticoagulant therapy
1984
Genetic requirements for mycobacterial survival during infection
2003 Standout
Comparing efficacy and safety of fibrinogen concentrate to cryoprecipitate in bleeding patients: a systematic review
2016
Clamping of the atherosclerotic ascending aorta during coronary artery bypass operations
1992
Designing Cell-Compatible Hydrogels for Biomedical Applications
2012 StandoutScience
Childhood Ischemic Stroke in a Nonurban Population
2005
Heme is a potent inducer of inflammation in mice and is counteracted by heme oxygenase
2001
Coagulopathy induced by acidosis, hypothermia and hypocalcaemia in severe bleeding.
2015
Acute resuscitation of the unstable adult trauma patient: bedside diagnosis and therapy.
2008
Heparin Blunts Endotoxin-Induced Coagulation Activation
1999
Dendrimers Designed for Functions: From Physical, Photophysical, and Supramolecular Properties to Applications in Sensing, Catalysis, Molecular Electronics, Photonics, and Nanomedicine
2010 Standout
Venous thrombosis: a multicausal disease
1999 Standout
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial
2010 Standout
Local and systemic hemostatics in trauma: a review.
2008
Development of a Point of Care Lateral Flow Device for Measuring Human Plasma Fibrinogen
2010 StandoutNobel
Tranexamic acid mouthwash versus autologous fibrin glue in patients taking warfarin undergoing dental extractions: a randomized prospective clinical study
2003
Decrease in protein C antigen and formation of an abnormal protein soon after starting oral anticoagulant therapy
1984
Chitosan Chemistry and Pharmaceutical Perspectives
2004 Standout
Antithrombotic Therapy for Venous Thromboembolic Disease
1995
Clamping of the atherosclerotic ascending aorta during coronary artery bypass operations. Its cost in strokes.
1992
Works of U. Martinowitz being referenced
Feasibility of using recombinant factor VIIa in continuous infusion.
1996
Dental extraction for patients on oral anticoagulant therapy
1990
The Use of Fibrin Tissue Adhesive to Reduce Blood Loss and the Need for Blood Transfusion After Total Knee Arthroplasty. A Prospective, Randomized, Multicenter Study*
1999
The role of fibrin tissue adhesives in surgery of haemophilia patients
1998
Treatment of obstetric hemorrhage with recombinant activated factor VII (rFVIIa)
2002
Evaluation of solvent/detergent treated plasma in the management of patients with hereditary and acquired coagulation disorders
1993
Fresh blood units contain large potent platelets that improve hemostasis after open heart operations
1992
Screening for mutations in the antithrombin III gene causing recurrent venous thrombosis by single-strand conformation polymorphism analysis
1993
Dental extractions in patients with bleeding disorders
1993
Dental extractions in patients maintained on oral anticoagulant therapy: Comparison of INR value with occurrence of postoperative bleeding
2001
Recombinant Activated Factor VII for Adjunctive Hemorrhage Control in Trauma
2001
Early Use of Recombinant Factor VIIa Improves Mean Arterial Pressure and May Potentially Decrease Mortality in Experimental Hemorrhagic Shock: A Pilot Study
2002
Effects of factor VIII inhibitor bypassing activity (FEIBA), recombinant factor VIIa or both on thrombin generation in normal and haemophilia A plasma
2008
Intra-patient variability of thromboelastographic parameters following in vivo and ex vivo administration of recombinant activated factor VII in haemophilia patients. A multi-centre, randomised trial
2009
Novel delivery systems for coagulation proteins
1998
The destructive capabilities of the synovium in the haemophilic joint
1998
The effect of fibrinogen concentrate on thrombocytopenia
2007
Phacoemulsification of Cataract in Patients Receiving Coumadin Therapy: Ocular and Hematologic Risk Assessment
2007
Updates in the management of severe coagulopathy in trauma patients
2002
Role of Fibrin Sealants in Surgical Procedures on Patients With Hemostatic Disorders
1996
Intravenous rFVIIa Administered for Hemorrhage Control in Hypothermic Coagulopathic Swine with Grade V Liver Injuries
2001
Females with von Willebrand disease: 72 years as the silent majority
1998
Fibrin sealant
1996
Administration off label of recombinant factor-VIIa (rFVIIa) to patients with blunt or penetrating brain injury without coagulopathy
2008
Clinical picture and treatment strategies in factor VII deficiency
1998
The molecular genetic analysis of haemophilia A; characterization of six partial deletions in the factor VIII gene
1990
Guidelines for the use of recombinant activated factor VII (rFVIIa) in uncontrolled bleeding: a report by the Israeli Multidisciplinary rFVIIa Task Force
2005
Dental extractions in patients maintained on continued oral anticoagulant: Comparison of local hemostatic modalities
1999
Viral Envelope Protein of HTLV-III is the Major Target Antigen for Antibodies in Hemophiliac Patients
1986
Recombinant Activated Factor VII for Adjunctive Hemorrhage Control in Trauma*
2001
Factor V Leiden and Antiphospholipid Antibodies Are Significant Risk Factors for Ischemic Stroke in Children
2000
Safety and Efficacy of Continuous Infusion of a Combined Factor VIII – von Willebrand Factor (vWF) Concentrate (Haemate-P™) in Patients with von Willebrand Disease
1999
Factor VIII immunogenicity
1998
Possible role of recombinant activated factor VII (rFVIIa) in the control of hemorrhage associated with massive trauma.
2002
The hemostatic effect of transfusing fresh whole blood versus platelet concentrates after cardiac operations
1988
Intracranial Hemorrhage in Patients with Hemophilia
1986
The molecular genetic analysis of hemophilia A: a directed search strategy for the detection of point mutations in the human factor VIII gene
1990
Safety and efficacy of continuous infusion of a combined factor VIII-von Willebrand factor (vWF) concentrate (Haemate-P) in patients with von Willebrand disease.
1999
Molecular analysis of Burkitt's leukemia in two hemophilic brothers with AIDS
1987
Platelet Aggregation on Extracellular Matrix: Effect of a Recombinant GPIb-Binding Fragment of von Willebrand Factor
1993
Fibrin Tissue Adhesives
1997
An Assay of the Antithrombotic Action of Warfarin: Its Correlation with the Inhibition of Stasis Thrombosis in Rabbits
1978
Effect of cardiac operation on platelets
1986
The effect of transfusion of fresh whole blood versus platelet concentrates after cardiac operations
1989
The effect of transfusion of fresh whole blood versus platelet concentrates after cardiac operations. A scanning electron microscope study of platelet aggregation on extracellular matrix.
1989
Is transfusion of fresh plasma after cardiac operations indicated?
1990